Biocon Limited Biocon Limited

Biocon Limited

BIOCON

Kedudukan dalam Saham #3387
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Harga Saham
$3.76
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$5.14B
Perubahan (1 hari)
-2.11%
Perubahan (1 tahun)
-9.31%
Negara
IN
Perdagangan Biocon Limited (BIOCON)

Kategori

Healthcare
Nisbah P/S bagi Biocon Limited (BIOCON)
Nisbah P/S pada October 2026 TTM: 2.80
Menurut laporan kewangan dan harga saham terkini Biocon Limited, nisbah P/S semasa (TTM) ialah 2.80. Pada akhir 2024, nisbah P/S syarikat ialah 2.19.
Sejarah nisbah P/S untuk Biocon Limited dari 2004 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
2026 (TTM) 2.80 5.35%
2025 2.66 21.75%
2024 2.19 -0.79%
2023 2.20 -54.89%
2022 4.88 -28.13%
2021 6.80 33.65%
2020 5.08 -23.50%
2019 6.65 -22.37%
2018 8.56 49.90%
2017 5.71 101.52%
2016 2.83 -6.69%
2015 3.04 12.72%
2014 2.70 18.90%
2013 2.27 -0.79%
2012 2.28 -22.10%
2011 2.93 7.96%
2010 2.72 34.93%
2009 2.01 -59.64%
2008 4.99 -12.65%
2007 5.71 -7.76%
2006 6.19 3.79%
2005 5.97 -26.97%
2004 8.17 0.00%
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.02 257.64%
US
40.55 1,347.05%
US
3.96 41.35%
AU
- -
CH
10.15 262.07%
NL